Health
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants – Newswise
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or…
Newswise — LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2…
Continue Reading
-
Noosa News23 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General16 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General19 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
Business17 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%